Skip to main content
. 2009 Mar 2;28(1):30. doi: 10.1186/1756-9966-28-30

Table 3.

Study and control groups.

Study group Control group Differences between groups, P value
hypercoagulability + - -

number of patients 28 28 -

male/female 20/8 21/7 0.33

median age 62 60.1 0.52

Prognostic factors

Good prognosis 15 pts (53.6%) 15 pts (53.6%) -

Poor prognosis 13 pts (46.4%) 13 pts (46.4%) -